Timing of myocarditis onset during immunotherapy for cancer may predict mortality risk

The timing of myocarditis onset during immunotherapy treatment for cancer may predict how likely a person is to die of the condition, according to retrospective study results.Patients who developed myocarditis within a month of starting immune checkpoint inhibitors (ICI) appeared more than twice as likely to die of the rare but potentially serious adverse event than those who developed it between